Skip to content

13F-HR filed by Alphabet Inc.

Alphabet Inc. filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-11-15, with 58 holding rows worth $4,141,375,000.

Accession
0001567619-22-020227
Filed
2022-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 67 entries on the cover page, a total value of $4,141,375,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,141,375,000 with VALUE read as thousands by filing date, 13F file number 028-22702. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UIPATH INC90364P105CL A14,068,674$606,781,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM10,974,011$404,612,000thousands by filing date
DEXCOM INC COM252131107Stock704,011$378,026,000thousands by filing date
IONQ INC COM46222L108Stock21,907,038$365,848,000thousands by filing date
TOASTINCCLASSCLASSA888787108STOK9,496,884$329,637,000thousands by filing date
EQRX INC26886C107COM47,552,687$324,309,000thousands by filing date
LYFT INC55087P104CL A COM6,138,154$262,283,000thousands by filing date
PLANET LABS PBC72703X106COM CL A31,942,641$196,445,000thousands by filing date
OSCAR HEALTH INC687793109CL A24,042,864$188,736,000thousands by filing date
BENSON HILL INC082490103COM14,752,271$107,544,000thousands by filing date
FRESHWORKS INC CLASS A COM358054104Stock4,035,595$105,975,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM2,563,441$103,742,000thousands by filing date
ROBINHOOD MKTS INC770700102COM4,928,535$87,531,000thousands by filing date
DESKTOP METAL INC25058X105COM CL A11,048,730$54,691,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock1,564,173$48,036,000thousands by filing date
LYELL IMMUNOPHARMA INC55083R104COM5,865,125$45,396,000thousands by filing date
23ANDME HOLDING CO90138Q108CLASS A COM6,736,785$44,867,000thousands by filing date
SANA BIOTECHNOLOGY INC799566104COM2,812,500$43,538,000thousands by filing date
INVIVYD INC00534A102COMMON STOCK5,680,785$41,242,000thousands by filing date
SCIENCE 37 HOLDINGS INC808644108COM3,241,075$40,416,000thousands by filing date
MONTE ROSA THERAPEUTICS INC61225M102COM1,464,015$29,895,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM321,604$25,629,000thousands by filing date
RAPT THERAPEUTICS INC75382E109COM627,762$23,058,000thousands by filing date
ILLUMINA INC452327109COM53,470$20,342,000thousands by filing date
ENJOY TECHNOLOGY INC29335V106COM4,345,340$20,076,000thousands by filing date
KRONOS BIO INC50107A104COM1,438,232$19,546,000thousands by filing date
VERA THERAPEUTICS INC92337R101COMMON STOCK713,658$19,069,000thousands by filing date
BARINTHUS BIOTHERAPEUTICS PL91864C107ADS1,704,344$18,935,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock753,187$17,805,000thousands by filing date
TENAYA THERAPEUTICS INC87990A106COM915,705$17,353,000thousands by filing date
DUOLINGO INC CL A COM26603R106Stock144,444$15,327,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock3,339,138$14,792,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM889,979$14,249,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK500,901$11,456,000thousands by filing date
AMPLITUDE INC COM CL A03213A104Stock189,447$10,029,000thousands by filing date
NEW RELIC INC64829B100COMMON STOCK91,132$10,021,000thousands by filing date
DECIBEL THERAPEUTICS INC24343R106COM1,636,258$7,609,000thousands by filing date
TAYSHA GENE THERAPIES INC877619106COMMON STOCK640,882$7,466,000thousands by filing date
SENTINELONE INC81730H109CL A138,503$6,993,000thousands by filing date
SINGULAR GENOMICS SYSTEMS IN82933R100COM586,584$6,781,000thousands by filing date
HYPERFINE INC44916K106Common Stock898,720$6,516,000thousands by filing date
EVELO BIOSCIENCES INC299734103COM1,060,495$6,437,000thousands by filing date
Tscan Therapeutics Inc89854M101COM1,077,080$4,847,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK255,452$4,519,000thousands by filing date
ALECTOR INC014442107COMMON STOCK175,866$3,632,000thousands by filing date
AUTOLUS THERAPEUTICS PLC SPON05280R100COM698,262$3,624,000thousands by filing date
INVITAE CORP46185L103COM215,965$3,300,000thousands by filing date
CORTEXYME INC22053A107COM189,122$2,387,000thousands by filing date
Uber Technologies90353T100COM49,466$2,074,000thousands by filing date
OPORTUN FINANCIAL CORP68376D104COMMON STOCK94,788$1,919,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock23,205$1,806,000thousands by filing date
TWILIO INC CL A90138F102Stock3,776$994,000thousands by filing date
SQZ BIOTECHNOLOGIES CO78472W104COM103,929$928,000thousands by filing date
NEXTDOOR HOLDINGS INC65345M108COM CL A97,391$768,000thousands by filing date
COMPASS THERAPEUTICS INC20454B104COM192,794$611,000thousands by filing date
WEWORK INC96209A104COM63,645$547,000thousands by filing date
S&P Global,Inc.78409V104COM592$279,000thousands by filing date
REPLIGEN CORP COM759916109Stock383$101,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-22-020227this filing2022-11-15acceptance time not in the bulk data set